Seven patients have been treated successfully for hemophilia B and so far essentially none have developed inhibitors, according to the results of phase I and II trials of Baxalta drug BAX 335.
December 2015
Advertisement
Advertisement
Trending on HCPLive
1
Navigating Emotional Burden in IBD
2
Highlighting FDA-Approved Therapies in Atopic Dermatitis, With Chris Bunick, MD, PhD
3
Open Communication Between Patients and Providers in IBD
4
Linaclotide in Pediatric IBS-C—Evidence, Indications, and Practical Use
5